Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

被引：22

作者：

Hermanova, Ivana ^{[1
]}

Zuniga-Garcia, Patricia ^{[1
]}

Caro-Maldonado, Alfredo ^{[1
]}

Fernandez-Ruiz, Sonia ^{[1
,2
]}

Salvador, Fernando ^{[2
,3
]}

Martin-Martin, Natalia ^{[1
,2
]}

Zabala-Letona, Amaia ^{[1
,2
]}

Nunez-Olle, Marc ^{[3
]}

Torrano, Veronica ^{[1
,2
,4
]}

Camacho, Laura ^{[1
,4
]}

Lizcano, Jose M. ^{[5
,6
]}

Talamillo, Ana ^{[1
]}

Carreira, Suzanne ^{[7
]}

Gurel, Bora ^{[7
]}

Cortazar, Ana R. ^{[1
,2
]}

Guiu, Marc ^{[3
]}

Lopez, Jose, I ^{[8
]}

Martinez-Romero, Anabel ^{[2
,9
]}

Astobiza, Ianire ^{[1
,2
]}

Valcarcel-Jimenez, Lorea ^{[1
]}

Lorente, Mar ^{[10
]}

Arruabarrena-Aristorena, Amaia ^{[1
]}

Velasco, Guillermo ^{[10
,11
]}

Gomez-Munoz, Antonio ^{[4
]}

Suarez-Cabrera, Cristian ^{[12
,13
]}

Lodewijk, Iris ^{[12
,13
]}

Flores, Juana M. ^{[14
]}

Sutherland, James D. ^{[1
]}

Barrio, Rosa ^{[1
]}

de Bono, Johann S. ^{[7
,15
]}

Paramio, Jesus M. ^{[2
,12
,13
]}

Trka, Jan ^{[16
,17
,18
]}

Graupera, Mariona ^{[2
,9
]}

Gomis, Roger R. ^{[2
,3
,19
]}

Carracedo, Arkaitz ^{[1
,2
,4
,20
]}

机构：

[1] BRTA, Ctr Cooperat Res Biosci, Derio, Spain

[2] CIBERONC Ctr Invest Biomed Red Canc, Madrid, Spain

[3] Barcelona Inst Sci & Technol, Inst Res Biomed, Canc Sci Program, Barcelona, Spain

[4] Univ Basque Country, Biochem & Mol Biol Dept, Bilbao, Spain

[5] Univ Autonoma Barcelona, Inst Neurociencies, Prot Kinases & Signal Transduct Lab, Barcelona, Spain

[6] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain

[7] Inst Canc Res, London, England

[8] Univ Basque Country, Cruces Univ Hosp, Biocruces Inst, Dept Pathol, Baracaldo, Spain

[9] Inst Invest Biomed Bellvitge, Vasc Signalling Lab, Program Canc Therapeut Resistance ProCURE, Barcelona, Spain

[10] Univ Complutense Madrid, Sch Biol, Dept Biochem & Mol Biol, Madrid, Spain

[11] Inst Invest Sanitarias San Carlos, Madrid, Spain

[12] Hosp Univ 12 Octubre, Grp Oncol Celular & Mol, Madrid, Spain

[13] Ctr Invest Energet Medioambientales & Tecnol, Unidad Oncol Mol, Madrid, Spain

[14] Univ Complutense Madrid, Sch Vet Med, Dept Anim Med & Surg, Madrid, Spain

[15] Royal Marsden Natl Hlth Serv Fdn Trust, London, England

[16] Childhood Leukaemia Invest, Prague, Czech Republic

[17] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol Oncol, Prague, Czech Republic

[18] Univ Hosp Motol, Prague, Czech Republic

[19] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain

[20] Basque Fdn Sci, Ikerbasque, Bilbao, Spain

来源：

JOURNAL OF EXPERIMENTAL MEDICINE | 2020年 / 217卷 / 06期

基金：

欧盟地平线“2020”; 欧洲研究理事会;

关键词：

CONSENSUS REPORT; MOUSE MODELS; PTEN LEADS; NEOPLASIA; CLASSIFICATION; EXPRESSION; HALLMARKS; PATHOLOGY; MUTATION; MARKERS;

D O I：

10.1084/jem.20191787

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Gene dosage is a key defining factor to understand cancer pathogenesis and progression, which requires the development of experimental models that aid better deconstruction of the disease. Here, we model an aggressive form of prostate cancer and show the unconventional association of LKB1 dosage to prostate tumorigenesis. Whereas loss of Lkbl alone in the murine prostate epithelium was inconsequential for tumorigenesis, its combination with an oncogenic insult, illustrated by Pten heterozygosity, elicited lethal metastatic prostate cancer. Despite the low frequency of LKB1 deletion in patients, this event was significantly enriched in lung metastasis. Modeling the role of LKB1 in cellular systems revealed that the residual activity retained in a reported kinase-dead form, LKB1(K781), was sufficient to hamper tumor aggressiveness and metastatic dissemination. Our data suggest that prostate cells can function normally with low activity of LKB1, whereas its complete absence influences prostate cancer pathogenesis and dissemination.

引用

页数：19

共 55 条

[1] The Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, Adam
Ahn, Jaeil
Akbani, Rehan
Ally, Adrian
Amin, Samirkumar
Andry, Christopher D.
Annala, Matti
Aprikian, Armen
Armenia, Joshua
Arora, Arshi
Auman, J. Todd
Balasundaram, Miruna
Balu, Saianand
Barbieri, Christopher E.
Bauer, Thomas
Benz, Christopher C.
Bergeron, Alain
Beroukhim, Rameen
Berrios, Mario
Bivol, Adrian
Bodenheimer, Tom
Boice, Lori
Bootwalla, Moiz S.
dos Reis, Rodolfo Borges
Boutros, Paul C.
Bowen, Jay
Bowlby, Reanne
Boyd, Jeffrey
Bradley, Robert K.
Breggia, Anne
Brimo, Fadi
Bristow, Christopher A.
Brooks, Denise
Broom, Bradley M.
Bryce, Alan H.
Bubley, Glenn
Burks, Eric
Butterfield, Yaron S. N.
Button, Michael
Canes, David
Carlotti, Carlos G.
Carlsen, Rebecca
Carmel, Michel
Carroll, Peter R.
Carter, Scott L.
Cartun, Richard
Carver, Brett S.
Chan, June M.
Chang, Matthew T.
Chen, Yu
[J]. CELL, 2015, 163 (04) : 1011 - 1025
[2] Genomic correlates of clinical outcome in advanced prostate cancer
Abida, Wassim
Cyrta, Joanna
Heller, Glenn
Prandi, Davide
Armenia, Joshua
Coleman, Ilsa
Cieslik, Marcin
Benelli, Matteo
Robinson, Dan
Van Allen, Eliezer M.
Sboner, Andrea
Fedrizzi, Tarcisio
Mosquera, Juan Miguel
Robinson, Brian D.
De Sarkar, Navonil
Kunju, Lakshmi P.
Tomlins, Scott
Wu, Yi Mi
Rodrigues, Daniel Nava
Loda, Massimo
Gopalan, Anuradha
Reuter, Victor E.
Pritchard, Colin C.
Mateo, Joaquin
Bianchini, Diletta
Miranda, Susana
Carreira, Suzanne
Rescigno, Pasquale
Filipenko, Julie
Vinson, Jacob
Montgomery, Robert B.
Beltran, Himisha
Heath, Elisabeth I.
Scher, Howard I.
Kantoff, Philip W.
Taplin, Mary-Ellen
Schultz, Nikolaus
deBono, Johann S.
Demichelis, Francesca
Nelson, Peter S.
Rubin, Mark A.
Chinnaiyan, Arul M.
Sawyers, Charles L.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (23) : 11428 - 11436
[3] Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Abida, Wassim
Armenia, Joshua
Gopalan, Anuradha
Brennan, Ryan
Walsh, Michael
Barron, David
Danila, Daniel
Rathkopf, Dana
Morris, Michael
Slovin, Susan
McLaughlin, Brigit
Curtis, Kristen
Hyman, David M.
Durack, Jeremy C.
Solomon, Stephen B.
Arcila, Maria E.
Zehir, Ahmet
Syed, Aijazuddin
Gao, Jianjiong
Chakravarty, Debyani
Vargas, Hebert Alberto
Robson, Mark E.
Vijai, Joseph
Offit, Kenneth
Donoghue, Mark T. A.
Abeshouse, Adam A.
Kundra, Ritika
Heins, Zachary J.
Penson, Alexander V.
Harris, Christopher
Taylor, Barry S.
Ladanyi, Marc
Mandelker, Diana
Zhang, Liying
Reuter, Victor E.
Kantoff, Philip W.
Solit, David B.
Berger, Michael F.
Sawyers, Charles L.
Schultz, Nikolaus
Scher, Howard I.
[J]. JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 26
[4] Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors
Agarwal, Supreet
Hynes, Paul G.
Tillman, Heather S.
Lake, Ross
Abou-Kheir, Wassim G.
Fang, Lei
Casey, Orla M.
Ameri, Amir H.
Martin, Philip L.
Yin, Juan Juan
Iaquinta, Phillip J.
Karthaus, Wouter R.
Clevers, Hans C.
Sawyers, Charles L.
Kelly, Kathleen
[J]. CELL REPORTS, 2015, 13 (10): : 2147 - 2158
[5] Subtle variations in Pten dose determine cancer susceptibility
Alimonti, Andrea
Carracedo, Arkaitz
Clohessy, John G.
Trotman, Lloyd C.
Nardella, Caterina
Egia, Ainara
Salmena, Leonardo
Sampieri, Katia
Haveman, William J.
Brogi, Edi
Richardson, Andrea L.
Zhang, Jiangwen
Pandolfi, Pier Paolo
[J]. NATURE GENETICS, 2010, 42 (05) : 454 - U136
[6] The long tail of oncogenic drivers in prostate cancer
Armenia, Joshua
Wankowicz, Stephanie A. M.
Liu, David
Gao, Jianjiong
Kundra, Ritika
Reznik, Ed
Chatila, Walid K.
Chakravarty, Debyani
Han, G. Celine
Coleman, Ilsa
Montgomery, Bruce
Pritchard, Colin
Morrissey, Colm
Barbieri, Christopher E.
Beltran, Himisha
Sboner, Andrea
Zafeiriou, Zafeiris
Miranda, Susana
Bielski, Craig M.
Penson, Alexander V.
Tolonen, Charlotte
Huang, Franklin W.
Robinson, Dan
Wu, Yi Mi
Lonigro, Robert
Garraway, Levi A.
Demichelis, Francesca
Kantoff, Philip W.
Taplin, Mary-Ellen
Abida, Wassim
Taylor, Barry S.
Scher, Howard I.
Nelson, Peter S.
de Bono, Johann S.
Rubin, Mark A.
Sawyers, Charles L.
Chinnaiyan, Arul M.
Schultz, Nikolaus
Van Allen, Eliezer M.
[J]. NATURE GENETICS, 2018, 50 (05) : 645 - +
[7] Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era
Arriaga, Juan M.
Abate-Shen, Cory
[J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (02):
[8] A continuum model for tumour suppression
Berger, Alice H.
Knudson, Alfred G.
Pandolfi, Pier Paolo
[J]. NATURE, 2011, 476 (7359) : 163 - 169
[9] Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability
Boudeau, J
Deak, M
Lawlor, MA
Morrice, NA
Alessi, DR
[J]. BIOCHEMICAL JOURNAL, 2003, 370 : 849 - 857
[10] Clinical features, treatment, prognosis, and outcome of 47 patients with pure squamous cell carcinoma of the prostate.
Brunnhoelzl, Daniel
Wang, Jue
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)

← 1 2 3 4 5 6 →